Top Markets
#1 Islamic Coin Islamic Coin +151.47%
#2 DOVU DOVU +49.95%
#3 Black Phoenix Black Phoenix +34.49%
#4 Velvet Velvet +32.46%
#5 Akedo Akedo +15.63%
#6 DoubleZero DoubleZero +13.65%
#7 HOME HOME +12.67%
#8 Cross Cross +12.27%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.90%
#10 Cap Cap +10.33%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Galera Therapeutics, Inc. Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

GRTX
Clasificación en acciones #33957
Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The company is also progressing with GC4711, another superoxide dismutase mimetic candidate, which is in a Phase I/II clinical trial. This trial evaluates its combination with stereotactic body radiation therapy (SBRT) for individuals diagnosed with non-small cell lung cancer and locally advanced pancreatic cancer. Galera Therapeutics was founded in 2012 and maintains its headquarters in Malvern, Pennsylvania.
Precio por acción
$17.15
Última sincronización: 2026-08-03
Capitalización bursátil
$6.51M
Cambio (1 día)
9.80%
Cambio (1 año)
289.77%
País
US
Comercio Galera Therapeutics, Inc. (GRTX)

Categoría

Healthcare
Número de acciones en circulación de Galera Therapeutics, Inc. (GRTX)
Número de acciones en circulación al March 2026: 98.62M
Según los últimos informes financieros y el precio de las acciones de Galera Therapeutics, Inc., el número actual de acciones en circulación es 98.62M. Al final de December 2023, la empresa tenía 44.55M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Galera Therapeutics, Inc. (GRTX) desde 2017 hasta 2026
Acciones en circulación al final de cada año
Año Acciones en circulación Cambiar
2026 (TTM) 98.62M 80.52%
2024 54.63M 22.64%
2023 44.55M 64.47%
2022 27.09M 5.03%
2021 25.79M 3.70%
2020 24.87M 0.24%
2019 24.81M 28.15%
2018 19.36M -98.73%
2017 1.52B 0.00%
Acciones en circulación de empresas similares o competidores
Empresa Acciones en circulación Diferencia País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 157.45%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -36.95%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE